Over the past decades, B-type natriuretic peptide (BNP) and its derivative N-terminal pro-BNP (NT-proBNP) have been increasingly investigated and highlighted as significant cardiovascular biomarkers, especially for heart failure (HF) and recently also for stroke [71,72]. Here, NPPB is linked to heart failure.